PI3K signaling has been reported to be activated in fibrotic lung disease33, with animal model studies of BLM-induced pulmonary fibrosis demonstrating that inhibition of the activation of the PI3K/Akt/m-TOR signaling pathway can alleviate pulmonary fibrosis34,35. This evidence concerns the gene MTOR and pulmonary fibrosis.